More strikingly, KCNE2 gene variants associated with drug-induced LQTS (diLQTS) in some cases increase the sensitivity of hERG in vitro to block by the specific drug that precipitated the arrhythmic episode in vivo (Abbott et al., 1999; Sesti et al., 2000). The gene discussed is KCNH2; the disease is familial long QT syndrome.